$305.28
At close: Apr 14, 4:00 PM EDT
$305.28
0.000.00%
After Hours: 4:00 PM EDT
Comments
Loading...
Medpace Hldgs Analyst Ratings and Price Targets | NASDAQ:MEDP | Benzinga
Medpace Holdings Inc has a consensus price target of $368.64 based on the ratings of 12 analysts. The high is $480 issued by UBS on March 8, 2024. The low is $328 issued by TD Cowen on April 14, 2025. The 3 most-recent analyst ratings were released by TD Cowen, Truist Securities, and Mizuho on April 14, 2025, April 10, 2025, and April 9, 2025, respectively. With an average price target of $338.67 between TD Cowen, Truist Securities, and Mizuho, there's an implied 10.94% upside for Medpace Holdings Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
TD Cowen
Truist Securities
Mizuho
Leerink Partners
Baird
1calculated from analyst ratings
Analyst Ratings for Medpace Hldgs
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 04/14/2025 | Buy Now | 7.44% | TD Cowen | Charles Rhyee37% | $370 → $328 | Downgrade | Buy → Hold | Get Alert |
| 04/10/2025 | Buy Now | 9.08% | Truist Securities | Jailendra Singh39% | $347 → $333 | Maintains | Hold | Get Alert |
| 04/09/2025 | Buy Now | 16.29% | Mizuho | Ann Hynes86% | $400 → $355 | Maintains | Outperform | Get Alert |
| 03/24/2025 | Buy Now | 8.1% | Leerink Partners | Michael Cherny78% | → $330 | Initiates | → Market Perform | Get Alert |
| 01/27/2025 | Buy Now | 18.58% | Baird | Eric Coldwell78% | $354 → $362 | Maintains | Neutral | Get Alert |
| 11/25/2024 | Buy Now | 15.96% | Baird | Eric Coldwell78% | $349 → $354 | Maintains | Neutral | Get Alert |
| 10/23/2024 | Buy Now | 21.86% | TD Cowen | Charles Rhyee37% | $413 → $372 | Maintains | Buy | Get Alert |
| 10/23/2024 | Buy Now | 14.32% | Baird | Eric Coldwell78% | $413 → $349 | Downgrade | Outperform → Neutral | Get Alert |
| 10/22/2024 | Buy Now | — | William Blair | Max Smock18% | — | Reiterates | → Outperform | Get Alert |
| 10/14/2024 | Buy Now | 32.34% | Redburn Atlantic | — | → $404 | Initiates | → Buy | Get Alert |
| 10/14/2024 | Buy Now | 30.04% | Truist Securities | Jailendra Singh39% | $415 → $397 | Maintains | Hold | Get Alert |
| 09/27/2024 | Buy Now | 14.65% | UBS | Dan Leonard56% | $420 → $350 | Downgrade | Buy → Neutral | Get Alert |
| 09/25/2024 | Buy Now | 13.01% | Jefferies | David Windley76% | $415 → $345 | Downgrade | Buy → Hold | Get Alert |
| 09/20/2024 | Buy Now | 35.29% | Baird | Eric Coldwell78% | $430 → $413 | Maintains | Outperform | Get Alert |
| 09/11/2024 | Buy Now | — | William Blair | Max Smock18% | — | Reiterates | → Outperform | Get Alert |
| 08/01/2024 | Buy Now | 35.94% | Truist Securities | Jailendra Singh39% | → $415 | Initiates | → Hold | Get Alert |
| 07/24/2024 | Buy Now | 41.51% | Guggenheim | Sandy Draper73% | $464 → $432 | Maintains | Buy | Get Alert |
| 07/24/2024 | Buy Now | 40.85% | Baird | Eric Coldwell78% | $469 → $430 | Maintains | Outperform | Get Alert |
| 07/24/2024 | Buy Now | 10.06% | Deutsche Bank | Justin Bowers49% | $395 → $336 | Maintains | Hold | Get Alert |
| 07/24/2024 | Buy Now | 42.16% | TD Cowen | Charles Rhyee37% | $452 → $434 | Maintains | Buy | Get Alert |
| 07/23/2024 | Buy Now | — | William Blair | Max Smock18% | — | Reiterates | → Outperform | Get Alert |
| 07/08/2024 | Buy Now | 53.63% | Baird | Eric Coldwell78% | $456 → $469 | Maintains | Outperform | Get Alert |
| 05/29/2024 | Buy Now | 48.06% | TD Cowen | Charles Rhyee37% | → $452 | Initiates | → Buy | Get Alert |
| 05/28/2024 | Buy Now | 42.49% | Mizuho | Ann Hynes86% | → $435 | Initiates | → Buy | Get Alert |
| 04/24/2024 | Buy Now | 51.99% | Guggenheim | Sandy Draper73% | $453 → $464 | Maintains | Buy | Get Alert |
| 04/24/2024 | Buy Now | 48.72% | Baird | Eric Coldwell78% | $446 → $454 | Maintains | Outperform | Get Alert |
| 04/23/2024 | Buy Now | 47.41% | Jefferies | David Windley76% | $340 → $450 | Upgrade | Hold → Buy | Get Alert |
| 03/18/2024 | Buy Now | 29.39% | Deutsche Bank | Justin Bowers49% | → $395 | Initiates | → Hold | Get Alert |
| 03/08/2024 | Buy Now | 57.23% | UBS | John Sourbeer30% | $452 → $480 | Maintains | Buy | Get Alert |
| 02/15/2024 | Buy Now | 48.06% | UBS | John Sourbeer30% | $282 → $452 | Upgrade | Neutral → Buy | Get Alert |
| 02/14/2024 | Buy Now | 33.65% | Baird | Eric Coldwell78% | $312 → $408 | Maintains | Outperform | Get Alert |
| 01/17/2024 | Buy Now | 2.2% | Baird | Eric Coldwell78% | $302 → $312 | Maintains | Outperform | Get Alert |
| 10/24/2023 | Buy Now | -5.33% | Baird | Eric Coldwell78% | $270 → $289 | Upgrade | Neutral → Outperform | Get Alert |
| 07/25/2023 | Buy Now | -10.57% | Guggenheim | Sandy Draper73% | $252 → $273 | Maintains | Buy | Get Alert |
| 05/08/2023 | Buy Now | -17.45% | Guggenheim | Sandy Draper73% | → $252 | Upgrade | Neutral → Buy | Get Alert |
| 02/15/2023 | Buy Now | -23.68% | Baird | Eric Coldwell78% | $226 → $233 | Maintains | Neutral | Get Alert |
| 10/27/2022 | Buy Now | — | UBS | John Sourbeer30% | — | Upgrade | Sell → Neutral | Get Alert |
| 10/26/2022 | Buy Now | -28.92% | Baird | Eric Coldwell78% | $200 → $217 | Maintains | Neutral | Get Alert |
| 09/07/2022 | Buy Now | -53.49% | UBS | John Sourbeer30% | → $142 | Initiates | → Sell | Get Alert |
| 05/24/2022 | Buy Now | — | Guggenheim | Sandy Draper73% | — | Initiates | → Neutral | Get Alert |
FAQ
What is the target price for Medpace Hldgs (MEDP) stock?
The latest price target for Medpace Hldgs (NASDAQ:MEDP) was reported by TD Cowen on April 14, 2025. The analyst firm set a price target for $328.00 expecting MEDP to rise to within 12 months (a possible 7.44% upside). 27 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Medpace Hldgs (MEDP)?
The latest analyst rating for Medpace Hldgs (NASDAQ:MEDP) was provided by TD Cowen, and Medpace Hldgs downgraded their hold rating.
When was the last upgrade for Medpace Hldgs (MEDP)?
The last upgrade for Medpace Holdings Inc happened on April 23, 2024 when Jefferies raised their price target to $450. Jefferies previously had a hold for Medpace Holdings Inc.
When was the last downgrade for Medpace Hldgs (MEDP)?
The last downgrade for Medpace Holdings Inc happened on April 14, 2025 when TD Cowen changed their price target from $370 to $328 for Medpace Holdings Inc.
When is the next analyst rating going to be posted or updated for Medpace Hldgs (MEDP)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Medpace Hldgs, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Medpace Hldgs was filed on April 14, 2025 so you should expect the next rating to be made available sometime around April 14, 2026.
Is the Analyst Rating Medpace Hldgs (MEDP) correct?
While ratings are subjective and will change, the latest Medpace Hldgs (MEDP) rating was a downgraded with a price target of $370.00 to $328.00. The current price Medpace Hldgs (MEDP) is trading at is $305.28, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.